The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Prevalence of Optimal Treatment Regimens in Patients With Apparent Treatment-Resistant Hypertension Based on Office Blood Pressure in a Community-Based Practice Network
Open accessAbstract
Hypertensive patients with clinical blood pressure (BP) uncontrolled on ≥3 antihypertensive medications (ie, apparent treatment-resistant hypertension [aTRH]) comprise ≈28% to 30% of all uncontrolled patients in the United States. However, the proportion receiving these medications in optimal doses is unknown; aTRH is used because treatment adherence and measurement artifacts were not available in electronic record data from our >200 community-based clinics Outpatient Quality Improvement Network. This study sought to define the proportion of uncontrolled hypertensives with aTRH on optimal regimens and clinical factors associated with optimal therapy. During 2007–2010, 468 877 hypertensive patients met inclusion criteria. BP <140/<90 mm Hg defined control. Multivariable logistic regression was used to assess variables independently associated with optimal therapy (prescription of diuretic and ≥2 other BP medications at ≥50% of maximum recommended hypertension doses). Among 468 877 hypertensives, 147 635 (31.5%) were uncontrolled; among uncontrolled hypertensives, 44 684 were prescribed ≥3 BP medications (30.3%), of whom 22 189 (15.0%) were prescribed optimal therapy. Clinical factors independently associated with optimal BP therapy included black race (odds ratio, 1.40 [95% confidence interval, 1.32–1.49]), chronic kidney disease (1.31 [1.25–1.38]), diabetes mellitus (1.30 [1.24–1.37]), and coronary heart disease risk equivalent status (1.29 [1.14–1.46]). Clinicians more often prescribe optimal therapy for aTRH when cardiovascular risk is greater and treatment goals lower. Approximately 1 in 7 of all uncontrolled hypertensives and 1 in 2 with uncontrolled aTRH are prescribed ≥3 BP medications in optimal regimens. Prescribing more optimal pharmacotherapy for uncontrolled hypertensives including aTRH, confirmed with out-of-office BP, could improve hypertension control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among treated adults with hypertension, prevalent aTRH occurs in ≈12% to 15% of population-based13–16 and 15% to 18% of clinic-based reports.17–20”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., Hendriksen, S. M., Kusek, J. W., & Lente, F. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,726
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
Self-citationUS trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Self-citationThe J-Curve Phenomenon in Hypertension
Kang, Y., & Wang, J. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,551
Cited by
Sorted by citations
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Self-citationTrends in Blood Pressure Among Adults With Hypertension
Yoon, S. S., Gu, Q., Nwankwo, T., Wright, J. D., Hong, Y., & Burt, V. L. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04012 · Cited by 260
Treatment of Resistant and Refractory Hypertension
Acelajado, M. C., Hughes, Z. H., Oparil, S., & Calhoun, D. A. (2019) · Circulation Research · doi:10.1161/circresaha.118.312156 · Cited by 226
Self-citationMadhur, M. S., Elijovich, F., Alexander, M. R., Pitzer, A. L., Ishimwe, J., Beusecum, J. P. V., Patrick, D. M., Smart, C. D., Kleyman, T. R., Kingery, J. R., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.318052 · Cited by 218
Achelrod, D., Wenzel, U. O., & Frey, S. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu151 · Cited by 200
The double challenge of resistant hypertension and chronic kidney disease
Rossignol, P., Massy, Z. A., Azizi, M., Bakris, G., Ritz, E., Covic, A., Goldsmith, D., Heine, G. H., Jager, K. J., Kanbay, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00418-3 · Cited by 194
Resistant Hypertension: A Review of Diagnosis and Management
Vongpatanasin, W. (2014) · JAMA · doi:10.1001/jama.2014.5180 · Cited by 146
Carotid baroreflex activation therapy for resistant hypertension
Victor, R. G. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.96 · Cited by 98
Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement
Bhatt, H., Siddiqui, M., Judd, E., Oparil, S., & Calhoun, D. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.03.186 · Cited by 77
Self-citationAfrican Americans, hypertension and the renin angiotensin system
Williams, S. F. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i9.878 · Cited by 72
Recognition and Management of Resistant Hypertension
Braam, B. G., Taler, S. J., Rahman, M., Fillaus, J. A., Greco, B., Forman, J. P., Reisin, E., Cohen, D. L., Saklayen, M. G., & Hedayati, S. S. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06180616 · Cited by 73
Impact of Baroreflex Activation Therapy on Renal Function - A Pilot Study
Wallbach, M., Lehnig, L.-Y., Schroer, C., Hasenfuss, G. P., Muller, G. A., Wachter, R., & Koziolek, M. J. (2014) · American Journal of Nephrology · doi:10.1159/000368723 · Cited by 57
Kario, K., Hoshide, S., Narita, K., Okawara, Y., Kanegae, H., Aoki, K., Kihara, H., Koga, T., Nakata, T., Oku, K., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18198 · Cited by 55
Hwang, A. Y., Dave, C., & Smith, S. M. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08128 · Cited by 54
Cai, A., & Calhoun, D. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.08929 · Cited by 54
Self-citationWei, Z., Spizzo, I., Diep, H., Drummond, G. R., Widdop, R. E., & Vinh, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114895 · Cited by 52
Detection, evaluation, and treatment of severe and resistant hypertension
White, W. B., Turner, J. R., Sica, D. A., Bisognano, J. D., Calhoun, D. A., Townsend, R. R., Aronow, H. D., Bhatt, D. L., & Bakris, G. L. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.06.005 · Cited by 48
Self-citationEffects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation
Azizi, M., Mahfoud, F., Weber, M. A., Sharp, A. S. P., Schmieder, R. E., Lurz, P. C., Lobo, M. D., Fisher, N. D. L., Daemen, J., Bloch, M. J., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3904 · Cited by 49
Self-citationLotufo, P. A., Pereira, A. C., Vasconcellos-Silva, P. R., Santos, I. S., Mill, J. G., & Benseñor, I. M. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12433 · Cited by 45
Azizi, M., Sharp, A. S. P., Fisher, N. D. L., Weber, M. A., Lobo, M. D., Daemen, J., Lurz, P. C., Mahfoud, F., Schmieder, R. E., Basile, J., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.066941 · Cited by 47
Self-citationEbinger, J. E., Kauko, A., FinnGen, Bello, N. A., Cheng, S. C., & Niiranen, T. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad066 · Cited by 40
Soluble Prorenin Receptor Increases Blood Pressure in High Fat–Fed Male Mice
Gatineau, E., Gong, M. C., & Yiannikouris, F. B. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12906 · Cited by 37
What is resistant arterial hypertension?
Shalaeva, E. V., & Messerli, F. H. (2023) · Blood Pressure · doi:10.1080/08037051.2023.2185457 · Cited by 45
Refractory versus resistant hypertension: Novel distinctive phenotypes.
Dudenbostel, T., Siddiqui, M., Gharpure, N., & Calhoun, D. A. (2017) · PubMed · Cited by 34
Self-citationVascular Mineralocorticoid Receptors
Lother, A., & Hein, L. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07418 · Cited by 34
Role of Aldosterone Blockade in Resistant Hypertension
Egan, B. M., & Li, J. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.04.004 · Cited by 33
Self-citationHayes, P., Casey, M., Glynn, L. G., Molloy, G. J., Durand, H., O'Brien, E. T., Dolan, E., Newell, J., & Murphy, A. W. (2018) · British Journal of General Practice · doi:10.3399/bjgp18x696221 · Cited by 33
Diagnosis and management of resistant hypertension
Sheppard, J. P., Martin, U., & McManus, R. J. (2017) · Heart · doi:10.1136/heartjnl-2015-308297 · Cited by 33
White-Coat Effect Is Uncommon in Patients With Refractory Hypertension
Siddiqui, M., Judd, E. K., Oparil, S., & Calhoun, D. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09464 · Cited by 27
Self-citationEbinger, J. E., Gluckman, T. J., Magraner, J., Chiu, S. T., Rider, D., Thomas, C., Das, S. R., Ho, P. M., Shreenivas, S., & Bradley, S. M. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.20894 · Cited by 26
Mallamaci, F., Torino, C., Sarafidis, P. A., Ekart, R., Loutradis, C., Siamopoulos, K. C., Giudice, A. D., Aucella, F., Morosetti, M., Raptis, V., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002448 · Cited by 24
Resistant hypertension: consensus document from the Korean society of hypertension
Park, S., Shin, J., Ihm, S., Kim, K., Kim, H., Kim, H. C., Lee, E. M., Lee, J. H., Ahn, S. Y., Cho, E. J., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00255-4 · Cited by 26
Calhoun, D. A. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.5.593 · Cited by 23
Self-citationDenolle, T., Chamontin, B., Doll, G., Fauvel, J.-P., Girerd, X. J., Herpin, D., Vaisse, B., Villeneuve, F., & Halimi, J.-M. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2015.122 · Cited by 24
Resistant or Refractory Hypertension: Are They Different?
Modolo, R., de Faria, A. P., Almeida, A. R., & Moreno, H. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0485-1 · Cited by 22
Recent advances in understanding and managing resistant/refractory hypertension
Doumas, M. N., Imprialos, K. P., Kallistratos, M. S., & Manolis, A. J. (2020) · F1000Research · doi:10.12688/f1000research.21669.1 · Cited by 23
Doogue, R., McCann, D., Fitzgerald, N., Murphy, A. W., Glynn, L. G., & Hayes, P. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01211-z · Cited by 20
Resistant Hypertension: Diagnosis and Management
Nagarajan, N., & Jalal, D. I. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.03.002 · Cited by 21
Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly
Kaboré, J., Metzger, M., Helmer, C., Berr, C., Tzourio, C., Massy, Z. A., & Stengel, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146056 · Cited by 20
Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension
Burnier, M., & Wuerzner, G. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.003 · Cited by 18
Wijkman, M. O., Malachias, M. V. B., Claggett, B. L., Cheng, S. C., Matsushita, K., Shah, A. M., Jhund, P. S., Coresh, J., Solomon, S. D., & Vardeny, O. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14269 · Cited by 18
Jafari, E. A., Cooper‐DeHoff, R. M., Effron, M. B., Hogan, W. R., & McDonough, C. W. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad084 · Cited by 20
Denolle, T., Chamontin, B., Doll, G., Fauvel, J., Girerd, X. J., Herpin, D., Vaisse, B., Villeneuve, F., & Halimi, J. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.07.016 · Cited by 18
Shuey, M. M., Gandelman, J. S., Chung, C. P., Nian, H., Yu, C., Denny, J. C., & Brown, N. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021640 · Cited by 19
Gijón‐Conde, T., Graciani, A., López‐García, E., Guallar‐Castillón, P., Rodríguez‐Artalejo, F., & Banegas, J. R. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.03.004 · Cited by 17
Chia, Y. C., Ahmad, W. A. W., Fong, A. Y. Y., Rosman, A., Rahman, A. R. A., Choo, G. H., Lim, S. K., Bakar, M. Z. A., & Ong, T. K. (2022) · Hypertension Research · doi:10.1038/s41440-022-00937-w · Cited by 17
Quality of Life in Treatment-Resistant Hypertension
Carris, N. W., & Smith, S. M. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0578-5 · Cited by 16
Evaluating factors associated with uncontrolled hypertension: Isfahan cohort study, Iran.
Khosravi, A., Pourheidar, B., Roohafza, H., Moezzi, M., Mousavi, M., Hajiannejad, A., Bidram, P., Gharipour, M., Shirani, S., Golshahi, J., et al. (2014) · Europe PMC (PubMed Central) · Cited by 16
Proceedings from Duke Resistant Hypertension Think Tank
Vemulapalli, S., Ard, J. D., Bakris, G. L., Bhatt, D. L., Brown, A. S., Cushman, W. C., Ferdinand, K. C., Flack, J. M., Fleg, J. L., Katzen, B. T., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.008 · Cited by 15
Multidisciplinary Approach in the Treatment of Resistant Hypertension
Potthoff, S. A., & Vonend, O. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0698-1 · Cited by 21
König, M., Gollasch, M., Rosada, A., Demuth, I., Spira, D., & Steinhagen‐Thiessen, E. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0580-0 · Cited by 14
Akinyelure, O. P., Jaeger, B. C., Safford, M. M., Oparil, S., Carson, A. P., Sims, A., Hannon, L., Howard, G., Muntner, P., & Hardy, S. T. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031695 · Cited by 14
The many faces of hypertension in individuals with type 1 diabetes
Lithovius, R., & Groop, P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110564 · Cited by 15
Behling, E. M., Garris, T., Blankenship, V., Wagner, S., Ramsey, D. J., Davis, R., Sutherland, S. E., Egan, B. M., Wozniak, G., Rakotz, M., et al. (2023) · Health Equity · doi:10.1089/heq.2022.0109 · Cited by 13
Self-citationHanuš, K., Prejbisz, A., Gąsowski, J., Klocek, M., Topór‐Mądry, R., Leśniak, W., Kabat, M., Czarnecka, D., Kawecka−Jaszcz, K., Narkiewicz, K., et al. (2017) · Kardiologia Polska · doi:10.5603/kp.a2017.0020 · Cited by 13
White, W. B., Bisognano, J. D., Calhoun, D. A., Townsend, R. R., Aronow, H. D., Bhatt, D. L., & Bakris, G. L. (2014) · Cited by 13
Self-citationWilson, A. L., Gandhi, J., Suh, Y., Joshi, G. S., Smith, N. L., & Khan, S. A. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190301154100 · Cited by 13
Ayisi‐Boateng, N. K., Mohammed, A., Opoku, D. A., & Sarfo, F. S. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13974 · Cited by 13
Validation of a Novel Renal Denervation System With Cryoablation
Ji, M., Chen, H., Shen, L., Zhang, Y., Yao, Z., Wu, Y., Xu, Y., & Ge, J. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.11.002 · Cited by 13
Drake, C., Lewinski, A. A., Rader, A., Schexnayder, J. K., Bosworth, H. B., Goldstein, K. M., Gierisch, J. M., White‐Clark, C., McCant, F., & Zullig, L. L. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01193-6 · Cited by 14
Treatment Resistant Hypertension
Egan, B. M. (2015) · Ethnicity & Disease · doi:10.18865/ed.25.4.495 · Cited by 13
Self-citationZekarias, K., & Tessier, K. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.11.085 · Cited by 13
Hassanein, M. (2020) · The Egyptian Heart Journal · doi:10.1186/s43044-020-00044-6 · Cited by 13
Clinical Diagnosis and Management of Resistant Hypertension
Tsioufis, C. P., Kasiakogias, A., & Tousoulis, D. M. (2016) · European Cardiology Review · doi:10.15420/ecr.2016:1:2 · Cited by 11
Fatemi, O., Goa, C., Faselis, C. J., Kokkinos, P. F., & Papademetriou, V. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12672 · Cited by 11
Choi, S. I., Kim, S. K., Park, S., Kim, J. H., Ihm, S., Kim, G.-I., Kim, W. S., Pyun, W. B., Kim, Y., & Shin, J. (2016) · Clinical Hypertension · doi:10.1186/s40885-016-0045-x · Cited by 11
Vemulapalli, S., Deng, L., Patel, M. R., Kilgore, M. L., Jones, W. S., Curtis, L. H., Irvin, M. R., Svetkey, L. P., Shimbo, D., Calhoun, D. A., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.01.008 · Cited by 11
Self-citationde la Sierra, A., Armario, P., Oliveras, A., Banegas, J. R., Gorostidi, M., Vinyoles, E., de la Cruz, J. J., Segura, J., & Ruilope, L. M. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001729 · Cited by 10
Renal denervation: Alternative treatment options for hypertension?
Gupta, A. A., Prince, M., Bob‐Manuel, T., & Jenkins, J. S. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.12.007 · Cited by 10
Maiolino, G., Azzolini, M., & Rossi, G. P. (2015) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00003 · Cited by 9
A comprehensive review of an unmet public health issue: resistant hypertension
Cai, A., Feng, Y., & Zhou, Y. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2016.1226892 · Cited by 10
Hypertension and Device-Based Therapies for Resistant Hypertension: An Up-to-Date Review
Tolu-Akinnawo, O. Z., Ray, D. N., Awosanya, T., Nzerue, C. M., & Okafor, H. T. (2024) · Cureus · doi:10.7759/cureus.66304 · Cited by 10
Device-Based Therapy for Resistant Hypertension: An Up‐to‐Date Review
Jami, O., Tijani, Y., & Ettahir, A. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00539-0 · Cited by 8
Izzo, R., Stabile, E., Esposito, G., Trimarco, V., Marco, M. D., Sica, A., Manzi, M. V., Gargiulo, G., Schiattarella, G. G., Rozza, F., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.022 · Cited by 8
Controversies in Hypertension V: Resistant and Refractory Hypertension
Filippone, E. J., Naccarelli, G. V., & Foy, A. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.09.015 · Cited by 10
Management of Resistant Hypertension: Do Not Give Up on Medication.
Judd, E. K., & Calhoun, D. A. (2014) · PubMed · Cited by 8
Self-citationZhang, H., Niu, H., Yuan, X., Chang, J. K., & Wang, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6278 · Cited by 8
Revisiting resistant hypertension in kidney disease
Bansal, S. (2024) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001002 · Cited by 7
Capítulo 13 - Hipertensão Arterial Resistente
Malachias, M. V. B., Souza, W., Plavnik, F. L., Rodrigues, C., Brandão, A., Neves, M. F., Bortolotto, L. A., Franco, R., Figueiredo, C., Jardim, P., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160163 · Cited by 7
Should All Patients with Resistant Hypertension Receive Spironolactone?
Rosa, J., Zelinka, T., Petrák, O., Štrauch, B., Holaj, R., & Widimsky, J., Jr. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0690-1 · Cited by 8
Pimenta, E., & Calhoun, D. A. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0634-9 · Cited by 7
Self-citationEgan, B. M., Laken, M. A., Sutherland, S. E., Qanungo, S., Fleming, D. O., Cook, A. G., Hester, W. H., Jones, K. W., Jebaily, G. C., Valainis, G. T., et al. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw016 · Cited by 6
Self-citationTrue versus pseudoresistant hypertension
Calhoun, D. A., & Grassi, G. M. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001568 · Cited by 6
Self-citationAdvances in resistant hypertension
Calhoun, D. A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.07.21 · Cited by 6
Self-citationAdvances in preclinical surgical therapy of cardiovascular diseases
Li, P., Chang, Y., & Song, J. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001534 · Cited by 5
Alshahawey, M., Jafari, E. A., Smith, S. M., & McDonough, C. W. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae227 · Cited by 6
Denisova, A. R., Solntseva, T. D., Анатольевна, С. О., & Chazova, I. E. (2021) · Systemic Hypertension · doi:10.26442/2075082x.2021.1.200724 · Cited by 5
Renal Sympathetic Denervation for Treatment of Resistant Hypertension: Egyptian Experience
Hamza, M. T., & Khamis, H. (2014) · Journal of Interventional Cardiology · doi:10.1111/joic.12135 · Cited by 5
Medication Exposure in Highly Adherent Psychiatry Patients
Sutherland, J. J., Daly, T. M., Jacobs, K., Khawam, E. A., Pozuelo, L., Morrison, R. D., Milne, S. B., Daniels, J. S., & Ryan, T. P. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00375 · Cited by 5
Siga, O., Wizner, B., Gryglewska, B., Walczewska, J., & Grodzicki, T. K. (2019) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2019.01.001 · Cited by 4
Hypertension control: population surveys vs clinical studies
Banegas, J. R., & Rodríguez‐Artalejo, F. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.7 · Cited by 4
Endovascular Baroreflex Amplification for Resistant Hypertension: What You Need to Know
Halim, J., Lycke, M., & der Heyden, J. V. (2020) · Future Cardiology · doi:10.2217/fca-2020-0003 · Cited by 4
A Medicaid Statewide Hypertension Quality Improvement Project: Initial Results
Bolen, S. D., Koroukian, S. M., Wright, J. T., Persaud, H., Einstadter, D., Fiegl, J., Perzynski, A. T., Gunzler, D. D., Sullivan, C., Lever, J., et al. (2023) · Cureus · doi:10.7759/cureus.36132 · Cited by 4
Hipertensión resistente: puesta al día
Renna, N. F. (2018) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2017.12.005 · Cited by 4
Egan, B. M., Li, J., Fleming, D. O., White, K., Connell, K., Davis, R. A., & Sinopoli, A. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12727 · Cited by 4
Self-citationEgan, B. M., & Cui, M. X. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21494 · Cited by 4
Self-citationNo Time to Waste: in Support of Aggressive and Immediate Management of Hypertension
Fudim, M., & Vemulapalli, S. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0640-y · Cited by 3
Resistant hypertension: a therapeutic challenge
Brandani, L. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13144 · Cited by 3
Resistant Hypertension: Questions and Contemporary Answers
Podzolkov, V. I., Bragina, A. E., & Osadchiy, K. K. (2019) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2019-15-4-568-577 · Cited by 3
Metadata
- Authors
- Egan, B. M., Zhao, Y., Li, J., Brzezinski, W. A., Todoran, T. M., Brook, R. D., & Calhoun, D. A.
- Affiliations
- Medical University of South Carolina (US)
- Venue
- Hypertension
- Published
- 2013-10
- Volume
- 62
- Issue
- 4
- Pages
- 691-697
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- PMC
- PMC4066303
- OpenAlex
- W2142011051
- Cited by
- 158
- References
- 37
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 13 · 2023: 16 · 2022: 12 · 2021: 6 · 2020: 10 · 2019: 8 · 2018: 12 · 2017: 14 · 2016: 21 · 2015: 16 · 2014: 22 · 2013: 3
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Heart, Lung, and Blood Institute (R34HL105880, R01HL091841, HL091841, HL105880)
- National Institute of Neurological Disorders and Stroke (NS058728, U01NS058728)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- apparent treatment-resistant hypertension, uncontrolled hypertension, office blood pressure, diuretics, chronic kidney disease, diabetes mellitus, coronary heart disease risk, racial disparities, hypertension control, community clinics
- MeSH terms
- Aged, Antihypertensive Agents, Black or African American, Blood Pressure, Blood Pressure Determination, Community Health Services, Female, Humans, Hypertension, Male, Middle Aged, Risk Factors, United States, Prevalence, Treatment Failure, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
